Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Cullinan Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 147
- +11 vs. Q3 2024
- Shares held
- 65.6M
- +579.9K (+0.9%) vs. Q3 2024
- Total value
- $798.8M
- −$288.2M (−26.5%) vs. Q3 2024
- New holders
- 31
- 54 more added
- Sold out
- 20
- 36 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 183 | $1.30B |
| Q1 2026 | 174 | $931.0M |
| Q4 2025 | 153 | $653.8M |
| Q3 2025 | 145 | $362.2M |
| Q2 2025 | 144 | $471.4M |
| Q1 2025 | 149 | $489.6M |
| Q4 2024 | 147 | $798.8M |
| Q3 2024 | 137 | $1.09B |
| Q2 2024 | 135 | $1.10B |
| Q1 2024 | 113 | $670.8M |
| Q4 2023 | 113 | $375.6M |
| Q3 2023 | 106 | $344.0M |
| Q2 2023 | 106 | $397.3M |
| Q1 2023 | 103 | $329.5M |
| Q4 2022 | 97 | $397.7M |
| Q3 2022 | 100 | $474.7M |
| Q2 2022 | 89 | $481.7M |
| Q1 2022 | 82 | $386.3M |
| Q4 2021 | 75 | $559.7M |
| Q3 2021 | 66 | $762.3M |
| Q2 2021 | 71 | $828.5M |
| Q1 2021 | 70 | $1.30B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Cullinan Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 155,270 | $1.89M | 0.00% | −254,523−62.1% | Reduced |
| Walleye Capital LLC | 156,497 | $1.91M | 0.02% | −171,920−52.3% | Reduced |
| Woodline Partners LP | 167,315 | $2.04M | 0.01% | +167,315 | New |
| Renaissance Technologies LLC | 190,508 | $2.32M | 0.00% | −91,292−32.4% | Reduced |
| JPMorgan Chase & Co | 198,214 | $2.41M | 0.00% | +169,104+580.9% | Added |
| Sphera Funds Management Ltd. | 205,000 | $2.50M | 0.46% | +19,129+10.3% | Added |
| Nuveen Asset Management, LLC | 227,033 | $2.77M | 0.00% | −6,533−2.8% | Reduced |
| UBS Group AG | 235,713 | $2.87M | 0.00% | +50,160+27.0% | Added |
| Barclays PLC | 245,231 | $2.99M | 0.00% | −3,383−1.4% | Reduced |
| Affinity Asset Advisors, LLC | 263,817 | $3.21M | 0.50% | 00.0% | Unchanged |
| Springhill Fund Asset Management (HK) Co Ltd | 276,400 | $3.37M | 5.47% | +276,400 | New |
| Charles Schwab Investment Management Inc | 430,971 | $5.25M | 0.00% | +7,012+1.7% | Added |
| Northern Trust Corp | 500,908 | $6.10M | 0.00% | +30,023+6.4% | Added |
| Ameriprise Financial Inc | 504,264 | $6.14M | 0.00% | +86,756+20.8% | Added |
| Deutsche Bank AG | 580,136 | $7.07M | 0.00% | +19,263+3.4% | Added |
| Twin Focus Capital Partners, LLC | 595,489 | $7.25M | 1.07% | 00.0% | Unchanged |
| Foresite Capital Management VI LLC | 634,558 | $7.73M | 3.44% | +634,558 | New |
| Morgan Stanley | 638,069 | $7.77M | 0.00% | −35,303−5.2% | Reduced |
| Marshall Wace, LLP | 651,693 | $7.94M | 0.01% | −402,071−38.2% | Reduced |
| Foresite Capital Management V, LLC | 657,905 | $8.01M | 6.67% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 685,374 | $8.35M | 0.00% | −15,178−2.2% | Reduced |
| Rock Springs Capital Management LP | 742,114 | $9.04M | 0.34% | +5,200+0.7% | Added |
| Millennium Management LLC | 833,962 | $10.2M | 0.01% | +45,395+5.8% | Added |
| Patient Square Capital LP | 878,897 | $10.7M | 4.00% | +54,192+6.6% | Added |
| Boxer Capital Management, LLC | 907,895 | $11.1M | 0.94% | +907,895 | New |
| Tang Capital Management LLC | 921,138 | $11.2M | 0.74% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,030,438 | $12.6M | 0.02% | −325,438−24.0% | Reduced |
| Nextech Invest AG | 1,141,145 | $13.9M | 2.25% | 00.0% | Unchanged |
| Braidwell LP | 1,176,173 | $14.3M | 0.42% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,211,357 | $14.8M | 0.65% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,214,641 | $14.8M | 0.00% | +6,220+0.5% | Added |
| Kynam Capital Management, LP | 1,252,738 | $15.3M | 1.01% | +1,252,738 | New |
| Lynx1 Capital Management LP | 1,257,795 | $15.3M | 5.74% | +846,965+206.2% | Added |
| Dimensional Fund Advisors LP | 1,318,372 | $16.1M | 0.00% | +295,467+28.9% | Added |
| VR Adviser, LLC | 1,379,965 | $16.8M | 1.15% | 00.0% | Unchanged |
| RTW Investments, LP | 1,705,960 | $20.8M | 0.31% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,942,555 | $23.7M | 0.49% | +872,500+81.5% | Added |
| Alliancebernstein L.P. | 2,011,525 | $24.5M | 0.01% | +157,115+8.5% | Added |
| State Street Corp | 2,124,484 | $25.9M | 0.00% | −212,738−9.1% | Reduced |
| Franklin Resources Inc | 2,199,709 | $26.8M | 0.01% | +8,447+0.4% | Added |
| Blue Owl Capital Holdings LP | 2,370,972 | $28.9M | 6.83% | +360,000+17.9% | Added |
| Citadel Advisors LLC | 2,682,904 | $32.7M | 0.03% | +727,647+37.2% | Added |
| Vanguard Group Inc | 2,936,227 | $35.8M | 0.00% | −62,487−2.1% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 3,379,399 | $41.2M | 0.78% | +99,399+3.0% | Added |
| BlackRock, Inc. | 4,371,025 | $53.2M | 0.00% | +32,300+0.7% | Added |
| BVF Inc | 5,750,683 | $70.0M | 2.37% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 7,648,268 | $93.2M | 13.23% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −2,321,013−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −1,533,579−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −907,895−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −425,000−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −182,810−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −148,773−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −54,358−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −36,624−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −25,369−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −20,840−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −20,404−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,245−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −10,788−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −956−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| ClariVest Asset Management LLC | – | – | – | – | Not filed |